Articles From: ConAgra Foods CEO Rodkin to retire after 9 years with company to Concord Medical Declares Special Dividend


NEW YORK (MarketWatch) -- ConAgra Foods (CAG) said Chief Executive Gary Rodkin, 62, plans to retire in May 2015, which is the end of the current fiscal year, after nearly nine yeasr at the company.
Sign-up for ConAgra Foods CEO Rodkin to retire after 9 years with company investment picks
ConAgra Foods, Inc., (NYSE:CAG) joined with community and civic leaders today to celebrate the completed expansion of its Lamb Weston frozen potato facility in Boardman, Ore.
Sign-up for ConAgra Foods Lamb Weston and Community Leaders Celebrate Boardman Plant Expansion investment picks
ConAgra Foods, Inc., (NYSE: CAG) one of North America’s leading food companies, today reported results for the fiscal 2014 fourth quarter ended May 25, 2014.
Sign-up for ConAgra Foods Reports Fiscal 2014 Fourth Quarter EPS; Non-Cash Impairment Charges Recognized With No Impact on Comparable EPS; Exceeds Operating Cash Flow and Debt Reduction Goals; Commitment to Strong Dividend Reaffirmed investment picks
ConAgra Foods, Inc. (NYSE: CAG) (“ConAgra Foods”) announced today the early tender results of its previously announced tender offer (the “Tender Offer”) to purchase for cash up to $500.0 million combined aggregate principal amount (the “Maximum Tender Amount”) of its 3.20% Senior Notes due 2023 (the “2023 Notes”), its 4.65% Senior Notes due 2043 (the “2043 Notes”), its 7.00% Senior Notes due 2019 (the “2019 Notes”), its 5.819% Senior Notes due 2017 (the “2017 Notes”) and its 2.10% Senior Notes due 2018 (the “2018 Notes” and, collectively with the 2023 Notes, the 2043 Notes, the 2019 Notes and the 2017 Notes, the “Notes”). The principal amount of each series of Notes that were validly tendered and not validly withdrawn as of 5:00 p.m., New York City time, on August 1, 2014 (the “Early Tender Date”) and the principal amount of each series of Notes that will be
Sign-up for ConAgra Foods, Inc. Announces Early Tender Results of Its Notes Tender Offer investment picks
ConAgra Foods, Inc. (NYSE:CAG) (“ConAgra Foods”) announced today it has commenced a tender offer (the “Tender Offer”) to purchase for cash up to $500.0 million combined aggregate principal amount (the “Maximum Tender Amount”) of its 3.20% Senior Notes due 2023 (the “2023 Notes”), its 4.65% Senior Notes due 2043 (the “2043 Notes”), its 7.00% Senior Notes due 2019 (the “2019 Notes”), its 5.819% Senior Notes due 2017 (the “2017 Notes”) and its 2.10% Senior Notes due 2018 (the “2018 Notes” and, collectively with the 2023 Notes, the 2043 Notes, the 2019 Notes and the 2017 Notes, the “Notes”). The amounts of each series of Notes that are purchased will be determined in accordance with the acceptance priority levels specified in the table below and on the cover page of the Offer to Purchase, dated July 21, 2014 (the “Offer to Purchase”), in the column entitled “Acceptance Priority Level” (the
Sign-up for ConAgra Foods, Inc. Announces Notes Tender Offer investment picks
ConAgra Foods, Inc. (NYSE: CAG) (“ConAgra Foods”) announced today the pricing of its previously announced tender offer (the “Tender Offer”) to purchase for cash up to $500.0 million combined aggregate principal amount (the “Maximum Tender Amount”) of its 3.20% Senior Notes due 2023 (the “2023 Notes”), its 4.65% Senior Notes due 2043 (the “2043 Notes”), its 7.00% Senior Notes due 2019 (the “2019 Notes”), its 5.819% Senior Notes due 2017 (the “2017 Notes”) and its 2.10% Senior Notes due 2018 (the “2018 Notes” and, collectively with the 2023 Notes, the 2043 Notes, the 2019 Notes and the 2017 Notes, the “Notes”). The amounts of each series of Notes that are purchased will be determined in accordance with the acceptance priority levels specified in the table below and on the cover page of the Offer to Purchase, dated July 21, 2014 (the “Offer to Purchase”), in the column entitled “Acceptance
Sign-up for ConAgra Foods, Inc. Announces Pricing of Notes Tender Offer investment picks
NEW YORK (MarketWatch) -- ConAgra Foods Inc. (CAG) said Thursday it swung to a loss of $324.2 million, or 77 cents a share, in the fiscal fourth quarter from a year-earlier profit of $192.2 million, or 46 cents a share.
Sign-up for ConAgra fourth-quarter revenue beats expectations investment picks
2014/6/18
By Michael Calia ConAgra Foods Inc. on Wednesday cut its earnings guidance, citing weakness in its consumer-foods and private-brand businesses.
Sign-up for ConAgra shares slump as it lowers outlook investment picks
SAN DIEGO, July 7, 2014 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) , a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease, today announced that it will relocate the company's corporate headquarters to a new leased facility in northern San Diego at 16745 W Bernardo Drive, Suite 200, San Diego, CA 92127.
Sign-up for Conatus Pharmaceuticals to Relocate Corporate Headquarters investment picks
SAN DIEGO, Aug.
Sign-up for Conatus Pharmaceuticals to Report Second Quarter 2014 Financial Results investment picks
2014/05/08
Would-be centenarians should hold more stocks and tweak their Social Security timing, among other strategies.
Sign-up for Concerned About Longevity: 4 Mistakes to Avoid investment picks
2014/7/11
Concerned ALCO Stockholders (“CAS”) , a group dedicated to maximizing stockholder value and improving corporate governance at ALCO Stores, Inc. (“ALCO”; Nasdaq:ALCS), today issued the following open letter to stockholders.
Sign-up for Concerned Alco Stockholders Asks ALCO Investors to Vote for the CAS Nominees to Effect the Critical Change Necessary at the Board of Directors of ALCO investment picks
2014/6/30
Concerned ALCO Stockholders (“CAS”) is a group dedicated to maximizing stockholder value and improving corporate governance at ALCO Stores, Inc. (“ALCO”; Nasdaq: ALCS). For this reason, CAS is in the process of finalizing and mailing to ALCO stockholders its proxy statement for the 2014 Annual Meeting of Stockholders of ALCO, scheduled to be held on July 30, 2014.
Sign-up for Concerned ALCO Stockholders Respond to ALCO Threatened Litigation investment picks
Concerned ALCO Stockholders (CAS) is dissatisfied that the incumbent Board of Directors of ALCO Stores, Inc. ("ALCO" or "the Company"; Nasdaq:ALCS) chose to ignore the overwhelming voice of the Company’s stockholders this morning by opening and then immediately adjourning today’s Annual Meeting without recognizing the stockholder votes for the four proposals in the proxy, including the election of the Company’s Directors and the extension of the Company’s Amended and Restated Rights Agreement (the “Rights Agreement”). The unofficial tally of the votes to elect the Directors of the Company cast prior to the Annual Meeting was as follows:
Sign-up for Concerned ALCO Stockholders Urges Incumbent Board to Cease Wasting Investor Resources and Accept the Will of the Stockholders investment picks
Concert Pharmaceuticals, Inc. (NASDQ: CNCE) today announced that it has achieved a $2 million milestone under its development and license agreement with Avanir Pharmaceuticals, Inc. for the clinical progression of AVP-786.
Sign-up for Concert Pharmaceuticals Achieves $2 Million Milestone for AVP-786 Under Avanir Pharmaceuticals Collaboration investment picks
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that the FDA has provided notification that the Company has completed the necessary preclinical toxicology testing in order to administer repeated doses of CTP-354 in excess of 6 mg per day, lifting its partial clinical hold.
Sign-up for Concert Pharmaceuticals Announces FDA Lifts Partial Clinical Hold for CTP-354, A Novel Drug Candidate for Spasticity investment picks
Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) today announced the successful completion of an End-of-Phase 2 meeting with the U.S. Food and Drug Administration (FDA) for CTP-499, its investigational therapy targeting diabetic nephropathy.
Sign-up for Concert Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for CTP-499 investment picks
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today reported financial results for the second quarter of 2014.
Sign-up for Concert Pharmaceuticals Reports Second Quarter 2014 Financial Results and Provides Company Update investment picks
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will present an overview at the Robert W.
Sign-up for Concert Pharmaceuticals to Present at Robert W. Baird 2014 Healthcare Conference on September 4, 2014 investment picks
Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will report its second quarter 2014 financial results on Tuesday, August 12, 2014 before the financial markets open.
Sign-up for Concert Pharmaceuticals to Report Second Quarter 2014 Results on August 12, 2014 investment picks
Concho Resources Inc. (NYSE: CXO) (the "Company") today announced its upcoming participation at the Barclays CEO Energy-Power Conference on Thursday, September 4 th at 8:25 AM EDT.
Sign-up for Concho Resources Inc. Announces Participation in Upcoming Conference investment picks
Concho Resources Inc. (NYSE: CXO) (the "Company") today announced its upcoming participation at the Tuohy Brothers 5 th Annual Energy Conference on Tuesday, August 12 th , EnerCom’s The Oil & Gas Conference 19 on Tuesday, August 19 th at 9:15 AM MDT and the Simmons 2014 European Energy Conference on Wednesday, August 27 th at 9:45 AM BST.
Sign-up for Concho Resources Inc. Announces Participation in Upcoming Conferences investment picks
Concho Resources Inc. (NYSE: CXO) (“Concho” or the “Company”) today reported financial and operating results for the second quarter and first half of 2014.
Sign-up for Concho Resources Inc. Reports Second Quarter 2014 Financial and Operating Results investment picks
Concho Resources Inc. (NYSE: CXO) (“Concho” or the “Company”) will host a conference call on Thursday, August 7, 2014, at 8:30 AM CDT to discuss its second quarter financial and operating results.
Sign-up for Concho Resources Inc. Schedules Second Quarter 2014 Conference Call for August 7, 2014 investment picks
Concho Resources Inc. (NYSE: CXO) (“Concho” or the “Company”) will host a conference call on Thursday, November 6, 2014, at 8:30 AM CST to discuss third quarter financial and operating results.
Sign-up for Concho Resources Inc. Schedules Third Quarter 2014 Conference Call for November 6, 2014 investment picks
BEIJING , June 25, 2014 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM) , a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China , today announced the new appointments to the management team.
Sign-up for Concord Medical Announces New Appointments to Management Team investment picks
BEIJING , July 28, 2014 /PRNewswire/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM) , a leading specialty hospital management solution provider and operator of the largest network of radiotherapy and diagnostic imaging centers in China , today announced that on July 28, 2014 , its Board of Directors declared a special cash dividend of US$0.30 per ordinary share (or US$0.90 per American Depositary Share ("ADS")) on the Company's outstanding ordinary shares.
Sign-up for Concord Medical Declares Special Dividend investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: ConAgra Foods CEO Rodkin to retire after 9 years with company to Concord Medical Declares Special Dividend
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices